 | • レポートコード：GIR-107A14489 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、マイトジェン活性化プロテインキナーゼ14のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。マイトジェン活性化プロテインキナーゼ14の種類別市場規模（メシル酸ラリメチニブ、ロスマピモド、ネフラマピモド、CHF-6297、その他）、用途別市場規模（慢性炎症、潰瘍性大腸炎、上皮性卵巣がん、胃がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・マイトジェン活性化プロテインキナーゼ14の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Array BioPharma Inc.、Astellas Pharma Inc.、AstraZeneca Plc、Chiesi Farmaceutici SpA、Chroma Therapeutics Limited、Eli Lilly and Company、GlaxoSmithKline Plc、Synovo GmbH、Toray Industries、Zocere, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：メシル酸ラリメチニブ、ロスマピモド、ネフラマピモド、CHF-6297、その他 ・用途別分析2016年-2026年：慢性炎症、潰瘍性大腸炎、上皮性卵巣がん、胃がん、その他 ・マイトジェン活性化プロテインキナーゼ14の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・マイトジェン活性化プロテインキナーゼ14のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・マイトジェン活性化プロテインキナーゼ14のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・マイトジェン活性化プロテインキナーゼ14の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・マイトジェン活性化プロテインキナーゼ14の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Mitogen Activated Protein Kinase 14 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Mitogen Activated Protein Kinase 14 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Mitogen Activated Protein Kinase 14 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Mitogen Activated Protein Kinase 14 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ralimetinib Mesylate
Losmapimod
Neflamapimod
CHF-6297
Others
Market segment by Application can be divided into
Chronic Inflammation
Ulcerative Colitis
Epithelial Ovarian Cancer
Gastric Cancer
Others
The key market players for global Mitogen Activated Protein Kinase 14 market are listed below:
Array BioPharma Inc.
Astellas Pharma Inc.
AstraZeneca Plc
Chiesi Farmaceutici SpA
Chroma Therapeutics Limited
Eli Lilly and Company
GlaxoSmithKline Plc
Synovo GmbH
Toray Industries
Zocere, Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Mitogen Activated Protein Kinase 14 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mitogen Activated Protein Kinase 14, with price, sales, revenue and global market share of Mitogen Activated Protein Kinase 14 from 2019 to 2021.
Chapter 3, the Mitogen Activated Protein Kinase 14 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mitogen Activated Protein Kinase 14 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Mitogen Activated Protein Kinase 14 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Mitogen Activated Protein Kinase 14 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Mitogen Activated Protein Kinase 14 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mitogen Activated Protein Kinase 14 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Ralimetinib Mesylate
1.2.3 Losmapimod
1.2.4 Neflamapimod
1.2.5 CHF-6297
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Mitogen Activated Protein Kinase 14 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Chronic Inflammation
1.3.3 Ulcerative Colitis
1.3.4 Epithelial Ovarian Cancer
1.3.5 Gastric Cancer
1.3.6 Others
1.4 Global Mitogen Activated Protein Kinase 14 Market Size & Forecast
1.4.1 Global Mitogen Activated Protein Kinase 14 Sales in Value (2016-2026))
1.4.2 Global Mitogen Activated Protein Kinase 14 Sales in Volume (2016-2026)
1.4.3 Global Mitogen Activated Protein Kinase 14 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Mitogen Activated Protein Kinase 14 Production Capacity Analysis
1.5.1 Global Mitogen Activated Protein Kinase 14 Total Production Capacity (2016-2026)
1.5.2 Global Mitogen Activated Protein Kinase 14 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mitogen Activated Protein Kinase 14 Market Drivers
1.6.2 Mitogen Activated Protein Kinase 14 Market Restraints
1.6.3 Mitogen Activated Protein Kinase 14 Trends Analysis
2 Manufacturers Profiles
2.1 Array BioPharma Inc.
2.1.1 Array BioPharma Inc. Details
2.1.2 Array BioPharma Inc. Major Business
2.1.3 Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Product and Services
2.1.4 Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Astellas Pharma Inc.
2.2.1 Astellas Pharma Inc. Details
2.2.2 Astellas Pharma Inc. Major Business
2.2.3 Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Product and Services
2.2.4 Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 AstraZeneca Plc
2.3.1 AstraZeneca Plc Details
2.3.2 AstraZeneca Plc Major Business
2.3.3 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product and Services
2.3.4 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Chiesi Farmaceutici SpA
2.4.1 Chiesi Farmaceutici SpA Details
2.4.2 Chiesi Farmaceutici SpA Major Business
2.4.3 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product and Services
2.4.4 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Chroma Therapeutics Limited
2.5.1 Chroma Therapeutics Limited Details
2.5.2 Chroma Therapeutics Limited Major Business
2.5.3 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product and Services
2.5.4 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product and Services
2.6.4 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 GlaxoSmithKline Plc
2.7.1 GlaxoSmithKline Plc Details
2.7.2 GlaxoSmithKline Plc Major Business
2.7.3 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product and Services
2.7.4 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Synovo GmbH
2.8.1 Synovo GmbH Details
2.8.2 Synovo GmbH Major Business
2.8.3 Synovo GmbH Mitogen Activated Protein Kinase 14 Product and Services
2.8.4 Synovo GmbH Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Toray Industries
2.9.1 Toray Industries Details
2.9.2 Toray Industries Major Business
2.9.3 Toray Industries Mitogen Activated Protein Kinase 14 Product and Services
2.9.4 Toray Industries Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Zocere, Inc.
2.10.1 Zocere, Inc. Details
2.10.2 Zocere, Inc. Major Business
2.10.3 Zocere, Inc. Mitogen Activated Protein Kinase 14 Product and Services
2.10.4 Zocere, Inc. Mitogen Activated Protein Kinase 14 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Mitogen Activated Protein Kinase 14 Sales by Manufacturer
3.1 Global Mitogen Activated Protein Kinase 14 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Mitogen Activated Protein Kinase 14 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Mitogen Activated Protein Kinase 14
3.4 Market Concentration Rate
3.4.1 Top 3 Mitogen Activated Protein Kinase 14 Manufacturer Market Share
3.4.2 Top 6 Mitogen Activated Protein Kinase 14 Manufacturer Market Share
3.5 Global Mitogen Activated Protein Kinase 14 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Mitogen Activated Protein Kinase 14 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mitogen Activated Protein Kinase 14 Market Size by Region
4.1.1 Global Mitogen Activated Protein Kinase 14 Sales in Volume by Region (2016-2026)
4.1.2 Global Mitogen Activated Protein Kinase 14 Revenue by Region (2016-2026)
4.2 North America Mitogen Activated Protein Kinase 14 Revenue (2016-2026)
4.3 Europe Mitogen Activated Protein Kinase 14 Revenue (2016-2026)
4.4 Asia-Pacific Mitogen Activated Protein Kinase 14 Revenue (2016-2026)
4.5 South America Mitogen Activated Protein Kinase 14 Revenue (2016-2026)
4.6 Middle East and Africa Mitogen Activated Protein Kinase 14 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Mitogen Activated Protein Kinase 14 Sales in Volume by Type (2016-2026)
5.2 Global Mitogen Activated Protein Kinase 14 Revenue by Type (2016-2026)
5.3 Global Mitogen Activated Protein Kinase 14 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Mitogen Activated Protein Kinase 14 Sales in Volume by Application (2016-2026)
6.2 Global Mitogen Activated Protein Kinase 14 Revenue by Application (2016-2026)
6.3 Global Mitogen Activated Protein Kinase 14 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Mitogen Activated Protein Kinase 14 Sales by Type (2016-2026)
7.2 North America Mitogen Activated Protein Kinase 14 Sales by Application (2016-2026)
7.3 North America Mitogen Activated Protein Kinase 14 Market Size by Country
7.3.1 North America Mitogen Activated Protein Kinase 14 Sales in Volume by Country (2016-2026)
7.3.2 North America Mitogen Activated Protein Kinase 14 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Mitogen Activated Protein Kinase 14 Sales by Type (2016-2026)
8.2 Europe Mitogen Activated Protein Kinase 14 Sales by Application (2016-2026)
8.3 Europe Mitogen Activated Protein Kinase 14 Market Size by Country
8.3.1 Europe Mitogen Activated Protein Kinase 14 Sales in Volume by Country (2016-2026)
8.3.2 Europe Mitogen Activated Protein Kinase 14 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Mitogen Activated Protein Kinase 14 Sales by Type (2016-2026)
9.2 Asia-Pacific Mitogen Activated Protein Kinase 14 Sales by Application (2016-2026)
9.3 Asia-Pacific Mitogen Activated Protein Kinase 14 Market Size by Region
9.3.1 Asia-Pacific Mitogen Activated Protein Kinase 14 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Mitogen Activated Protein Kinase 14 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Mitogen Activated Protein Kinase 14 Sales by Type (2016-2026)
10.2 South America Mitogen Activated Protein Kinase 14 Sales by Application (2016-2026)
10.3 South America Mitogen Activated Protein Kinase 14 Market Size by Country
10.3.1 South America Mitogen Activated Protein Kinase 14 Sales in Volume by Country (2016-2026)
10.3.2 South America Mitogen Activated Protein Kinase 14 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Type (2016-2026)
11.2 Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Application (2016-2026)
11.3 Middle East & Africa Mitogen Activated Protein Kinase 14 Market Size by Country
11.3.1 Middle East & Africa Mitogen Activated Protein Kinase 14 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Mitogen Activated Protein Kinase 14 Typical Distributors
12.3 Mitogen Activated Protein Kinase 14 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Mitogen Activated Protein Kinase 14 Revenue by Type, (USD Million), 2021-2026
Table 2. Global Mitogen Activated Protein Kinase 14 Revenue by Application, (USD Million), 2021-2026
Table 3. Array BioPharma Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Array BioPharma Inc. Major Business
Table 5. Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Product and Services
Table 6. Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Pharma Inc. Major Business
Table 9. Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Product and Services
Table 10. Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Plc Major Business
Table 13. AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product and Services
Table 14. AstraZeneca Plc Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Chiesi Farmaceutici SpA Basic Information, Manufacturing Base and Competitors
Table 16. Chiesi Farmaceutici SpA Major Business
Table 17. Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product and Services
Table 18. Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Chroma Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table 20. Chroma Therapeutics Limited Major Business
Table 21. Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product and Services
Table 22. Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company Major Business
Table 25. Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product and Services
Table 26. Eli Lilly and Company Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline Plc Major Business
Table 29. GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product and Services
Table 30. GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Synovo GmbH Basic Information, Manufacturing Base and Competitors
Table 32. Synovo GmbH Major Business
Table 33. Synovo GmbH Mitogen Activated Protein Kinase 14 Product and Services
Table 34. Synovo GmbH Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Toray Industries Basic Information, Manufacturing Base and Competitors
Table 36. Toray Industries Major Business
Table 37. Toray Industries Mitogen Activated Protein Kinase 14 Product and Services
Table 38. Toray Industries Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Zocere, Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Zocere, Inc. Major Business
Table 41. Zocere, Inc. Mitogen Activated Protein Kinase 14 Product and Services
Table 42. Zocere, Inc. Mitogen Activated Protein Kinase 14 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Mitogen Activated Protein Kinase 14 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 44. Global Mitogen Activated Protein Kinase 14 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Mitogen Activated Protein Kinase 14, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Mitogen Activated Protein Kinase 14 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 47. Head Office and Mitogen Activated Protein Kinase 14 Production Site of Key Manufacturer
Table 48. Mitogen Activated Protein Kinase 14 New Entrant and Capacity Expansion Plans
Table 49. Mitogen Activated Protein Kinase 14 Mergers & Acquisitions in the Past Five Years
Table 50. Global Mitogen Activated Protein Kinase 14 Sales by Region (2016-2021e) & (K Pcs)
Table 51. Global Mitogen Activated Protein Kinase 14 Sales by Region (2021-2026) & (K Pcs)
Table 52. Global Mitogen Activated Protein Kinase 14 Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Mitogen Activated Protein Kinase 14 Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Mitogen Activated Protein Kinase 14 Sales by Type (2016-2021e) & (K Pcs)
Table 55. Global Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Pcs)
Table 56. Global Mitogen Activated Protein Kinase 14 Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Mitogen Activated Protein Kinase 14 Price by Type (2016-2021e) & (USD/Pcs)
Table 59. Global Mitogen Activated Protein Kinase 14 Price by Type (2021-2026) & (USD/Pcs)
Table 60. Global Mitogen Activated Protein Kinase 14 Sales by Application (2016-2021e) & (K Pcs)
Table 61. Global Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Pcs)
Table 62. Global Mitogen Activated Protein Kinase 14 Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Mitogen Activated Protein Kinase 14 Price by Application (2016-2021e) & (USD/Pcs)
Table 65. Global Mitogen Activated Protein Kinase 14 Price by Application (2021-2026) & (USD/Pcs)
Table 66. North America Mitogen Activated Protein Kinase 14 Sales by Country (2016-2021e) & (K Pcs)
Table 67. North America Mitogen Activated Protein Kinase 14 Sales by Country (2021-2026) & (K Pcs)
Table 68. North America Mitogen Activated Protein Kinase 14 Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Mitogen Activated Protein Kinase 14 Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Mitogen Activated Protein Kinase 14 Sales by Type (2016-2021e) & (K Pcs)
Table 71. North America Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Pcs)
Table 72. North America Mitogen Activated Protein Kinase 14 Sales by Application (2016-2021e) & (K Pcs)
Table 73. North America Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Pcs)
Table 74. Europe Mitogen Activated Protein Kinase 14 Sales by Country (2016-2021e) & (K Pcs)
Table 75. Europe Mitogen Activated Protein Kinase 14 Sales by Country (2021-2026) & (K Pcs)
Table 76. Europe Mitogen Activated Protein Kinase 14 Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Mitogen Activated Protein Kinase 14 Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Mitogen Activated Protein Kinase 14 Sales by Type (2016-2021e) & (K Pcs)
Table 79. Europe Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Pcs)
Table 80. Europe Mitogen Activated Protein Kinase 14 Sales by Application (2016-2021e) & (K Pcs)
Table 81. Europe Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Pcs)
Table 82. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales by Region (2016-2021e) & (K Pcs)
Table 83. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales by Region (2021-2026) & (K Pcs)
Table 84. Asia-Pacific Mitogen Activated Protein Kinase 14 Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Mitogen Activated Protein Kinase 14 Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales by Type (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Pcs)
Table 88. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales by Application (2016-2021e) & (K Pcs)
Table 89. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Pcs)
Table 90. South America Mitogen Activated Protein Kinase 14 Sales by Country (2016-2021e) & (K Pcs)
Table 91. South America Mitogen Activated Protein Kinase 14 Sales by Country (2021-2026) & (K Pcs)
Table 92. South America Mitogen Activated Protein Kinase 14 Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Mitogen Activated Protein Kinase 14 Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Mitogen Activated Protein Kinase 14 Sales by Type (2016-2021e) & (K Pcs)
Table 95. South America Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Pcs)
Table 96. South America Mitogen Activated Protein Kinase 14 Sales by Application (2016-2021e) & (K Pcs)
Table 97. South America Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Pcs)
Table 98. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Country (2016-2021e) & (K Pcs)
Table 99. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Country (2021-2026) & (K Pcs)
Table 100. Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Type (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Pcs)
Table 104. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Application (2016-2021e) & (K Pcs)
Table 105. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Pcs)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Mitogen Activated Protein Kinase 14 Typical Distributors
Table 109. Mitogen Activated Protein Kinase 14 Typical Customers
List of Figures
Figure 1. Mitogen Activated Protein Kinase 14 Picture
Figure 2. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type in 2020
Figure 3. Ralimetinib Mesylate
Figure 4. Losmapimod
Figure 5. Neflamapimod
Figure 6. CHF-6297
Figure 7. Others
Figure 8. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Application in 2020
Figure 9. Chronic Inflammation
Figure 10. Ulcerative Colitis
Figure 11. Epithelial Ovarian Cancer
Figure 12. Gastric Cancer
Figure 13. Others
Figure 14. Global Mitogen Activated Protein Kinase 14 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Mitogen Activated Protein Kinase 14 Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Mitogen Activated Protein Kinase 14 Sales (2016-2026) & (K Pcs)
Figure 17. Global Mitogen Activated Protein Kinase 14 Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Mitogen Activated Protein Kinase 14 Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Mitogen Activated Protein Kinase 14 Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Mitogen Activated Protein Kinase 14 Market Drivers
Figure 21. Mitogen Activated Protein Kinase 14 Market Restraints
Figure 22. Mitogen Activated Protein Kinase 14 Market Trends
Figure 23. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Manufacturer in 2020
Figure 24. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Manufacturer in 2020
Figure 25. Mitogen Activated Protein Kinase 14 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Mitogen Activated Protein Kinase 14 Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Mitogen Activated Protein Kinase 14 Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Region (2016-2026)
Figure 29. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Region (2016-2026)
Figure 30. North America Mitogen Activated Protein Kinase 14 Revenue (2016-2026) & (USD Million)
Figure 31. Europe Mitogen Activated Protein Kinase 14 Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Mitogen Activated Protein Kinase 14 Revenue (2016-2026) & (USD Million)
Figure 33. South America Mitogen Activated Protein Kinase 14 Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue (2016-2026) & (USD Million)
Figure 35. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2016-2026)
Figure 36. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Type (2016-2026)
Figure 37. Global Mitogen Activated Protein Kinase 14 Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2016-2026)
Figure 39. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Application (2016-2026)
Figure 40. Global Mitogen Activated Protein Kinase 14 Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2016-2026)
Figure 42. North America Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2016-2026)
Figure 43. North America Mitogen Activated Protein Kinase 14 Sales Market Share by Country (2016-2026)
Figure 44. North America Mitogen Activated Protein Kinase 14 Revenue Market Share by Country (2016-2026)
Figure 45. United States Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2016-2026)
Figure 49. Europe Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2016-2026)
Figure 50. Europe Mitogen Activated Protein Kinase 14 Sales Market Share by Country (2016-2026)
Figure 51. Europe Mitogen Activated Protein Kinase 14 Revenue Market Share by Country (2016-2026)
Figure 52. Germany Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Mitogen Activated Protein Kinase 14 Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Mitogen Activated Protein Kinase 14 Revenue Market Share by Region (2016-2026)
Figure 61. China Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2016-2026)
Figure 68. South America Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2016-2026)
Figure 69. South America Mitogen Activated Protein Kinase 14 Sales Market Share by Country (2016-2026)
Figure 70. South America Mitogen Activated Protein Kinase 14 Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Mitogen Activated Protein Kinase 14 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
二重特異性分裂促進因子活性化タンパク質キナーゼ(MAPK)市場：世界及び中国市場分析・予測（～2024年） Dual Specificity Mitogen Activated Protein Kinase Kinase 1 Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Dual Specificity Mitogen Activated Protein Kinase Kinase 1 industry with a focus on the Chinese market. The report prov…- 世界のプロテインキナーゼCイプシロンタイプ市場 2021：企業別、地域別、種類・用途別 The Protein Kinase C Epsilon Type market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のMAPキナーゼ相互作用セリンプロテインキナーゼ1市場 2021：企業別、地域別、種類・用途別 The MAP Kinase Interacting Serine Protein Kinase 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 世界のチロシンプロテインキナーゼ受容体TYRO3市場 2021：企業別、地域別、種類・用途別 The Tyrosine Protein Kinase Receptor TYRO3 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界の3ホスホイノシチド依存性プロテインキナーゼ1市場 2021：企業別、地域別、種類・用途別 The 3 Phosphoinositide Dependent Protein Kinase 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…